Imperial Holdings Limited has acquired a 70% stake in a Dutch pharmaceutical wholesaler to enhance its logistic capabilities and expand its presence in the African healthcare market.
Target Information
Imperial Holdings Limited, a prominent logistics and supply chain company, has aimed to solidify its position in the African pharmaceutical market through a strategic acquisition. The company has recently announced the acquisition of a 70% stake in a leading Dutch pharmaceutical and medical supplies wholesaler, thereby enhancing its operational capabilities and expanding its reach in the healthcare sector across Africa.
This target company is recognized for its extensive distribution network and established presence, which aligns with Imperial's vision of offering improved healthcare solutions and logistics efficiency within the region. This acquisition is set to facilitate Imperial's entry into the Dutch supply chain landscape and leverage the company’s expertise in pharmaceutical distribution.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target's Country
The Dutch pharmaceutical market is one of the most developed in Europe, characterized by cutting-edge research and a robust regulatory framework. With a significant focus on innovation and sustainability, the industry has seen increasing demand for efficient
Similar Deals
Edwards Lifesciences → JenaValve Technology
2026
Adicon Holdings Limited → Crown Bioscience Inc.
2026
Imperial
invested in
Surgipharm
in 2020
in a Other deal